The oxidation of PTH(1-34) catalyzed by ferrous ethylenediaminetetraacetic acid (EDTA) is sitespecific. The oxidation of PTH(1-34) is localized primarily to the residues Met[8] and His [9] . Beyond the transformation of Met [8] and His[9] into methionine sulfoxide and 2-oxo-histidine, respectively, we observed a hydrolytic cleavage between Met[8] and His[9]. This hydrolysis requires the presence of Fe II and oxygen and can be prevented by diethylenetriaminepentaacetic acid (DTPA) and phosphate buffer. Conditions leading to this site-specific hydrolysis also promote the transformation of Met[8] into homocysteine, indicating that the hydrolysis and transformation of homocysteine may proceed through a common intermediate.
INTRODUCTION
Protein oxidation is frequently observed in biological aging [1] [2] [3] and represents a common problem limiting the stability of protein formulations. 4 Frequently, the mechanisms leading to protein oxidation in pharmaceutical formulations are not well understood due to the manifold of possible reactions and the potential for varying degrees of protein and/or excipient impurities to influence reactions pathways. Specific oxidants can react selectively with individual amino acids and form specific oxidation products depending on the reaction conditions (i.e., the nature of the formulation). A classic example is the reaction of hydrogen peroxide, which predominantly oxidizes Met to Met sulfoxide; [5] [6] [7] [8] however, in the presence of transition metals, hydrogen peroxide can be converted to hydroxyl radicals through the Fenton reaction. 9 In contrast to hydrogen peroxide, hydroxyl radicals react with all amino acids. 10 Frequently, protein formulations are contaminated by transition metals introduced through buffers, protein, and excipients or leaching from the metal container. When proteins contain binding sites for such transition metals, transition metal-catalyzed oxidation reactions can occur site-specifically, where the respective target sites for oxidation on a protein are defined by the location of the metal-binding sites. An important example is the oxidation of His residues and/or amino acids (e.g., Met) in close vicinity to His residues, which constitute binding sites for transition metals. [11] [12] [13] Here, the binding of the catalytic metal to His directs the oxidation toward amino acid targets in protein domains, which would not necessarily be targeted for oxidation based on solvent-accessible surface area. For example, the metal-catalyzed oxidation of human relaxin resulted in the oxidation of His and Met. 14 Among two Met residues, Met(B4) was oxidized to a higher extent than Met(B25), rationalized by the presence of metal-binding residues in the vicinity of Met(B4). In contrast, the exposure to human relaxin to hydrogen peroxide alone resulted in the opposite preference, a higher oxidation sensitivity of Met(B25). It was also demonstrated that, during the preparation of a recombinant humanized monoclonal antibody fragment in the presence of polysorbate 20, metal-binding to His [31] (in the Fab region) mediated the oxidation of Trp [50] . 15 The mechanisms of metal-catalyzed oxidation are complex, involving a manifold of potential short-lived intermediates such as freely diffusible and/or metal-bound hydroxyl radicals as well as metal-bound peroxides. Importantly, the extent to which these intermediates may be responsible for protein oxidation may vary from protein to protein based on protein conformation and the geometries of the metal-binding sites. In addition, the nature of the redox-active metal will define the actual oxidation mechanism. Based on product and kinetic isotope effects, the metal-catalyzed oxidation of human growth hormone by Cu II /ascorbate likely involves hydroxyl radicals (HO • ). 12 In contrast, scavenger studies during the oxidation of small Met-containing peptides by the classic Fenton system, [Fe II (EDTA)] 2-/H 2 O 2 , are more consistent with a "complexed" or metal-bound hydroxyl radical. 16 
MATERIALS AND METHODS

Materials
Human parathyroid hormone (1-34) (PTH(1-34)) (SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF, mol wt: 4117.72 Da, Figure 1 ) was supplied by American Peptide Co. Inc. (Sunnyvale, CA, USA). The PTH Met [8] Ala mutant was synthesized at Genentech (South San Francisco, CA, USA). Ammonium acetate (AAc), sodium phosphate (NaH 2 PO 4 ), iron(II) sulfate heptahydrate (FeSO 4 × 7H 2 O), iron(III) sulfate hydrate (Fe 2 (SO 4 ) 3 × H 2 O), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), N-ethylmaleimide (NEM), and catalase from bovine liver were supplied by Sigma-Aldrich (St. Louis, MO, USA) at the highest purity grade. Hydrogen peroxide (H 2 O 2 , 30%) was supplied by Fisher Scientific (Pittsburgh, PA, USA). Sequencing trypsin grade was supplied by Promega (Madison, WI, USA). To ensure that our solutions were not contaminated by any protease, some control experiments were performed according to the experimental protocols 1 and 5 (see below Section 2.3) in the presence of protease inhibitors (cOmplete ULTRA Tablets, Roche, Indianapolis, IN, USA). In addition, to probe for potential bacterial contamination, a series of control experiments was performed with solutions which had been subjected to sterile filtration, using a sterile syringe filter equipped with a 0.2 μm membrane (Corning Incorporated, New York, NY, USA) and used in a sterile room.
Digestion of PTH(1-34) and PTH(1-34) Met[8]Ala
PTH(1-34) and PTH(1-34) Met [8] Ala were digested with trypsin (1 μg/mL) in ammonium bicarbonate buffer (50 mM, pH 8.0) at 37 °C for 3 h. The digestion was either performed under air or Ar. This experimental parameter is given in Section 2.3 along with the description of the different protocols for the oxidation of PTH(1-34) and its mutant.
The proteolytic cleavage sites are presented in Figure 1 . Fragments F1-F4 indicate the location of tryptic peptides shared by PTH(1-34) and PTH(1-34) Met [8] Ala, which are rather insensitive to chemical modification by the Fenton reaction. Fragments F5 and F5A indicate the location of the N-terminal tryptic fragments of PTH and PTH(1-34) Met [8] Ala, respectively, which are the predominant target sites for modification by the Fenton reaction. Although PTH is not very hydrophobic and could have been analyzed as an intact protein by high-performance liquid chromatography, we preferred to tryptic digest PTH. The possible formation of cross-links during the metal-catalyzed oxidation of PTH may generate high molecular weight products. Indeed, the oxidation of Tyr and Phe residues can mediate the formation of cross-links with amino groups through Michael addition. 17 
Oxidation of PTH(1-34) by the Fenton Reaction
PTH(1-34) was oxidized according to different protocols, referred to as Exp.1-Exp.10, schematically displayed in Figure 2 . The stock solutions of Fe II /EDTA, Fe II /DTPA, and H 2 O 2 were prepared at a concentration of 10 mM in ammonium acetate buffer (20 mM, pH 6.9). The stock solution of DTPA was prepared at a concentration of 1 mM in ammonium acetate buffer (20 mM, pH 6.9). PTH(1-34) and catalase were prepared at a concentration of 24.3 μM (0.1 mg/mL) and 1.4 μM, respectively, in ammonium acetate buffer (20 mM, pH 6.9). The stock solutions of Fe II /EDTA, Fe II /DTPA, H 2 O 2 , and PTH(1-34) were always prepared and kept under Ar. Subsequently, the incubation of the reaction mixtures was performed either under air (Exp. 1-4 and 8) or under Ar (Exp. 5-7). After 15 min reaction time, 25 μL of catalase (1.4 μM) were added to the final solution to remove H 2 O 2 . When applicable, digestions were performed in the presence of air, according to the protocol described in Section 2.2. Figure 2a) / PTH(1-34) = 1:1:0.24 (it is important to note that not all oxidants generated through reactions 1-4 will be available to react with PTH(1-34) as these oxidants also readily react with [Fe II (EDTA)] 2-). 18 The reaction vial was opened to air, and after 30 min of incubation at 37 °C under air, 250 μL of the reaction sample were diluted with 250 μL of DTPA (1 mM) (the use of DTPA serves to terminate a hydrolysis reaction which will be confirmed in Exp. 2 below). Digestion was performed according to the protocol given in Section 2.2.
Protocol Exp. 1 (
30 min of incubation at 37 °C under air, 250 μL of the reaction sample were diluted with 250 μL of DTPA (1 mM). After 15 min, 25 μL of catalase (1.4 μM) were added to the final solution. This sample was not digested.
Detection of Homocysteine-PTH(1-34)
was oxidized according to the experimental protocols Exp. 1 (Section 2.3.1) and Exp. 9 (Section 2.3.9). After oxidation, NEM (1 mM) was added to the sample. The pH of the solution was adjusted to 8.0 by the addition of NaOH. After incubation at 37 °C for 30 min, β-mercaptoethanol (10 mM) was added to the solution prior to the start of the digestion. The digestion was performed according to the protocol described in Section 2.1. NEM served to alkylate the thiol group of the homocysteine residue.
Sample Preparation for Capillary LC-MS Analysis
LC-MS analyses of the reaction mixtures (prepared according to the protocols Exp.1-10) were performed on a Capillary Liquid Chromatography System (Waters Corporation, Milford, MA, USA). Samples of 10 μL of each sample were injected onto a C18 Vydac column (25 cm × 0.5 mm, 3.5 μm) and eluted with a linear gradient delivered at the rate of 20 μL/min. Mobile phases consisted of water/acetonitrile/formic acid at a ratio of 99%, 1%, and 0.08% (v:v:v) for solvent A and a ratio of 1%, 99%, and 0.06% (v:v:v) for solvent B. The following linear gradient was set: 10-50% of solvent B within 30 min.
Nano-Electrospray Ionization Time-of-Flight MS (ESI-TOF-MS) Analysis
ESI-MS spectra of undigested PTH and of the peptide digests were acquired on a SYNAPT-G2 (Waters Corp., Milford, MA). The SYNAPT-G2 instrument was operated for maximum resolution with all lenses optimized on the [M + 2H] 2+ ion from the [Glu] 1 -fibrinopeptide B. The cone voltage was 45 V, and Ar was admitted to the collision cell. The spectra were acquired using a mass range of 50-2000 amu (= atomic mass unit). The data were accumulated for 0.7 s per cycle.
MS/MS Analysis
The proteolytic digest of PTH(1-34) was analyzed either by means of a SYNAPT-G2 (Waters Corp., Milford, MA, USA) or an LTQ-FT mass spectrometer (Thermo Finnigan, West Palm Beach, FL, USA) under conditions described elsewhere. 19 On the SYNAPT-G2, MS/MS spectra were acquired by setting the MS 1 quadrupole to transmit a precursor mass window of ±0.1 amu. The MS/MS spectra were analyzed with the software MassMatrix [20] [21] [22] [23] and ProteinLynx Global Server from Waters Corp. (Milford, MA, USA). On the LTQ-FT mass spectrometer, peptides were separated on a reverse-phase LC Packings PepMap C18 column (0.300 × 150 mm) at a flow rate of 10 μL/min with a linear gradient rising from 0 to 65% acetonitrile in 0.06% aqueous formic acid over a period of 55 min using LC Packing Ultimate Chromatograph (Dionex). LC-MS experiments were performed in a datadependent acquisition manner using the Xcalibur 2.0 software (Thermo Scientific West Palm Beach, FL, USA). The five most intensive precursor ions in a survey MS 1 mass spectrum acquired in the Fourier transform-ion cyclotron resonance over a mass range of 300-2000 m/z were selected and fragmented in the linear ion trap by collision-induced dissociation. The ion selection threshold was 500 counts. For both instruments, the theoretical fragments were compared to the experimental MS/MS spectra to validate the structures of the products. The structures were validated only if the differences between the theoretical and the experimental m/z of the parent ion (and the fragment ions) were strictly below 0.1 Da.
RESULTS
The MS/MS spectra of the unmodified tryptic fragments of a PTH control are presented in Figure S1 -S5 (Supporting Information). The experimental protocols (Exp. 1-10) are summarized in Figure 2 . A list of the sequences of the tryptic fragments of PTH , PTH(1-34) Met [8] Ala) and of some oxidation products are presented in Table 1 . The results are succinctly summarized in Table 2 . The relative quantification of the oxidation products was obtained by (i) calculation of the peak area for each product from the LC-MS chromatograms (total ion counts, TIC) and (ii) the calculation of the ratio: area of the peak of interest/sum of the peak areas.
Nature of Oxidation Products of PTH(1-34)
Prior to the complete description of the LC-MS chromatograms obtained after oxidation of PTH(1-34), we shall present here an overview over the different products of oxidation.
The Fenton oxidation of PTH(1-34) under air and Ar leads to the formation of three major products, P1, P2, and P3 (Table 1 ). These products are fully characterized by their CID spectra presented in Figures 4, 5 , and S6. Table 1 ). The MS/MS sequencing of P2 is presented in Figure  5 . The presence of the y1 fragment ion clearly demonstrates that Met [8] represents the Cterminal residue of P2.
Product P3-P3 (m/z 1487.3) is the result of the oxidation of the residues Met [8] and His [9] to MetSO and 2-oxo-histidine, 24 respectively (Table 1 ). The MS/MS sequencing of P3 is presented in the Supporting Information ( Figure S6 ). The fragment ions y4 (m/z 431.3) and y6 (m/z 731.4) and the presence of b8 (m/z 904.4) demonstrate the incorporation of one oxygen into each residue, Met [8] and His [9] . The oxidation of PTH(1-34) by H 2 O 2 under air leads to the formation of two major products, P1 and P3. Product P1 has been described above.
Product P4-In product P4, Met [8] is replaced by homocysteine. The characterization and mechanism of formation of P4 is described in more detail below (Section 3.12).
Because products P1, P2, and P3 are related to the oxidation of the residues Met [8] or Met [8] and His [9] , which belong to the tryptic fragment F5, the yield of these products will be given throughout this paper as the relative ratio of conversion of F5 into its respective products of oxidation, P1, P2, or P3.
Oxidation products of Met [18] , Trp [23] , and His [32] only formed at trace levels during the Fenton oxidation of PTH(1-34). Figure 2 ) shows the same LC-MS profile ( Figure 6B ,D) independent of the addition of DTPA prior to the addition of catalase. Oxidation of PTH(1-34) under such conditions results in the formation of P1 and P2 (monitored after proteolytic digestion). In fact, the ratios of P1/F5 and P2/F5 are equal to 82% and 12% without the addition of DTPA and 83% and 11% with the addition of DTPA (Figure 3 ). Under these experimental conditions, the addition of DTPA after 30 min reaction time had no effect on the product yields of P1 and P2 since both reactions were complete prior to the addition of DTPA. As the samples were exposed to air prior to the addition of DTPA, the formation of P2 likely occurred during air-exposure (see also below). Product P2 was also observed by MS analysis when PTH(1-34) was not digested after Fenton oxidation. This demonstrates that the hydrolytic cleavage observed between Met [8] and His [9] did not occur during proteolytic digestion. Figure 2 ) reveals only the formation of P1 ( Figure 6C ), while product P2 is not formed. The ratio P1/F5 reached 23% under these conditions ( Figure 3 ). We can conclude that the addition of DTPA prevented the formation of P2 and decreased the yield of oxidation of Met [8] , that is, the conversion of F5 into P1.
Fenton Oxidation of PTH(1-34)
Oxidation of PTH(1-34) under Ar: Exp. 5 and 6
PTH(1-34) was oxidized in the presence of Fe II /EDTA and H 2 O 2 . All of the samples were maintained under Ar, from the preparation of the stock solutions until the end of the proteolytic digestion.
In the Absence of DTPA (Exp. 5)-After oxidation of PTH , no DTPA was added to the solution prior to digestion, and the reaction mixture was exposed to air only prior to LC-MS analysis ( Figure 2) . LC-MS analysis shows the formation of products P1 and P2 with a relative yield of 12% (P1/F5) and 34% (P2/F5), respectively ( Figure 7A and Figure  3 ).
Variation of the pH (Exp. 5)-
The pH was changed to 7.9 and 4.5 by the addition of NaOH or HCl, respectively, to the solution. At pH 7.9, no significant changes were observed compared to pH 6.9. Under acidic condition, pH 4.5, product P2 was not observed. The yield P1/F5 was 100% ( Figure S7 ).
In the Presence of DTPA (Exp. 6)-Immediately after the oxidation of PTH(1-34), DTPA was added to the solution while still under Ar. The comparison of the LC-MS data ( Figure 7A and B) demonstrates that the hydrolytic cleavage leading to the formation of P2 does not occur during LC-MS analysis. After proteolytic digestion, LC-MS analysis revealed only the formation of product P1 with a relative yield (P1/F5) of 10% ( Figure 7B and Figure 3 ). Figure  8A ; control, Figure 8B , is displayed to localize the peak corresponding to F5). The result of this experiment supports the observations emphasized in Exp. 1 vs 5 and Exp. 1 vs 2 that the formation of P2 requires the presence of molecular oxygen and Fe II . Hence, EDTA is not necessary for the formation of P2 (see Section 3.7).
Oxidation of PTH(1-34) in the Presence of DTPA and H 2 O 2 but Absence of Fe II
PTH(1-34) was oxidized according to the protocol Exp. 7. The LC-MS analysis presented in Figure 9 shows that the tryptic fragment F5 was completely transformed into product P1. Under these conditions of oxidation, 100% of Met [8] was therefore converted into MetSO. Product P2 was not formed.
Oxidation of PTH(1-34) Using Fe III
Following the experimental protocol Exp. 8, product P2 was not formed if PTH Figure S8A ). Product P1 was formed. The relative yield of conversion P1/F5 was 13%.
Oxidation of PTH(1-34) in Phosphate Buffer
The experimental protocol Exp. 1 (Section 2.3.1) was modified to replace ammonium acetate buffer with potassium phosphate buffer. In potassium phosphate buffer, the oxidation of PTH in the presence of Fe II /EDTA and H 2 O 2 did not yield P2 ( Figure S8A ). Product P1 was observed with a relative yield P1/F5 = 12%.
Oxidation of PTH(1-34) Using Fe II without EDTA and H 2 O 2
PTH(1-34) was oxidized according to the experimental protocol Exp. 9. After incubation of PTH in the presence of only Fe II in Ar at 37 °C, the solution was exposed to air. After digestion, LC-MS analysis revealed the formation of P2 with a relative yield P2/F5 = 13%. P1 was observed with a relative yield P1/F5 = 5% ( Figure S9 ).
Oxidation of PTH(1-34) in the Presence of Added Methionine
PTH(1-34) was oxidized according to the protocol of Exp. 1 (Section 2.3.1), except that methionine (1 mM) was added to the solution prior to incubation. The exogenous methionine prevented the formation of P2 (relative yield P2/F5 < 0.5%).
Preoxidation of PTH(1-34) by H 2 O 2 , Followed by Fenton Oxidation
PTH(1-34) was preoxidized with H 2 O 2 under air prior to Fenton oxidation according to the experimental protocol Exp. 1. A representative LC-MS analysis of such preoxidized PTH(1-34) is presented in Figure 10 . After proteolytic digestion, in addition to the unmodified tryptic fragments (F2-F4), LC-MS analysis reveals the presence of products P1 and P3 (Table 1 ). The absence of the tryptic fragment F5 demonstrates the conversion of Met [8] and His [9] into MetSO (P1) and 2-oxo-His (P3). The ratio P3/P1 = 50% indicates that 66% of F5 is converted into P1 (ratio P1/F5) and 33% into P3 (ratio P3/F5) (considering that the total amount of F5 is converted into P1 and P3, F5 = P1 + P3). After Fenton oxidation, no significant other products are observed. In particular, the absence of P2 suggests that neither P1 nor P3 is a suitable precursor for P2. Figure  11 ) does not show any significant difference. Hence, the substitution of Met [8] by Ala [8] prevented the hydrolysis of the peptide bond between Ala [8] and His [9] . If the hydrolysis between Ala [8] and His [9] had occurred, we would have expected to observe the formation of product P2A (m/z 846.4, Table 1 ). The absence of P2A during the Fenton oxidation of PTH(1-34) Met [8] Ala demonstrates the involvement of Met [8] in the hydrolysis mechanism during the Fenton oxidation of PTH(1-34).
Oxidation of PTH(1-34) Met[8]Ala under Air
PTH(1-34) Met[8]Ala was oxidized according to the experimental protocol Exp. 1 (Section 2.3.1). A comparison of nonoxidized (control) and oxidized PTH(1-34) Met[8]Ala (
Oxidation of PTH(1-34) in H 2 O 18
A mass spectrometry analysis in the range of m/z 906.0-912.0 ( Figure 12 ) reveals that after 
Conversion of Met[8] into Homocysteine
During the Fenton oxidation of PTH , in the presence of [Fe II /EDTA] 2-and H 2 O 2 , we observed the transformation of Met [8] into homocysteine. The homocysteine residue was fully characterized by the MS/MS analysis of product P4 ( Figure 13 ) and P4-NEM ( Figure  14) , generated by alkylation of P4 with NEM. The structure of P4 is characterized by the presence of the a7, b8, y5, and y6 fragment ions, which demonstrate the loss of 14 Da from the Met [8] residue originally present in the tryptic fragment F5 (Figure 13 ). P4-NEM contains two NEM groups located at the homocysteine and at C-terminal Lys residues, respectively. The structure of P4-NEM is characterized by the series of b3-b6, b8, b9, b11, and b12 fragment ions, and multiple internal fragment ions (e.g., EIQLu 1 , u 1 HNLG) ( Figure  14 ). The latter demonstrate that the homocysteine residue (labeled "u 1 " in the sequence) is derivatized with NEM. The y1-y3 fragment ions allow the identification of the C-terminal lysine (labeled "u 2 " in the sequence) as the second residue derivatized with NEM. Noteworthy, the conversion of Met [8] into homocysteine was observed along with the formation of P2. In contrast, when PTH(1-34) was oxidized under conditions where P2 was not observed, no transformation of Met [8] into homocysteine was observed either. Those results point to a common intermediate in the formation of the hydrolysis product P2 and the homocysteine-containing product P4. However, when PTH-(1-34) was oxidized in the presence of MeOH (1 M) or in the absence of H 2 O 2 , only the formation of P2 but not that of P4 was detected.
DISCUSSION
To predict oxidation and stability problems for protein pharmaceuticals, more detailed mechanistic studies are necessary, which characterize and quantify oxidation products for specific oxidation pathways as a function of peptide and protein sequence and conformational properties. Such mechanistic studies are here presented for the Fenton oxidation of parathyroid hormone (1-34), PTH(1-34) , a suitable model protein, which contains a number of oxidizable amino acids such as His, Met, Trp, and Tyr. 25 . Such association can be through coordination of the metal to an appropriate amino acid side chain (e.g., of His). In addition, the electrostatic interaction of EDTA with His has been documented by 1 H NMR studies, for example, for bovine pancreatic ribonuclease, 36 suggesting that overall negatively charged complexes of Fe II and Fe III with EDTA and DTPA may show similar interactions with other proteins.
PTH(1-34) was easily modified under air in the presence of [Fe II /EDTA] 2-. These conditions resulted in a hydrolytic cleavage between Met [8] and His [9] , which depended on the presence of Fe II and O 2 . Importantly, the presence of H 2 O 2 increased the yield of oxidation of Met [8] into MetSO but lowered the hydrolysis of the peptide bond between Met [8] and His [9] . In addition, the presence of exogenous Met during the oxidation of PTH or the mutation of Met [8] to Ala [8] prevented the hydrolytic reaction. In addition to these observations, the oxidation of Met [8] into MetSO prevented the hydrolytic reaction. These observations suggest that an unmodified sulfur in Met [8] is required to initiate the formation of an intermediate, which can lead to the hydrolysis of the peptide bond Met [8] His [9] . This intermediate is most likely an oxidized sulfur, such as the sulfide radical cation C2 displayed in Scheme 1. The formation of such an oxidized intermediate is consistent with the protective role of exogenous Met (competing for the oxidizing species) and also the formation of product P4 (see Scheme 2) . We observed that Met [18] , Trp [23] , and His [32] were hardly oxidized under our experimental conditions. Besides, no hydrolytic cleavage around the residues Met [18] and His [32] was observed. Such observations indicate that the proximity (in space and in the sequence) of the residues Met and His promotes the hydrolysis of the peptide bond that links these two residues.
In the following, we will rationalize our experimental results to explain how molecular oxygen, Fe II , Met [8] and His [9] can interact to drive the cleavage of the peptide bond between Met [8] and His [9] . Our hypothesis is that the hydrolytic reaction can occur in a complex involving PTH(1-34) (likely through His [9] ) and a peroxo-iron species. The involvement of His coordination in the formation of P2 is suggested by the observed pHdependency, where no formation of P2 was observed at pH 4.5, that is, when the His residue was protonated. A preliminary discussion about the possible nature of the peroxo-iron complex is, therefore, mandatory to explain the mechanism leading to the specific hydrolysis of the peptide bond between Met [8] and His [9] .
The Primary Oxidizing Species
Experiments under Ar-The precursors leading to the oxidizing species are presented in reactions 1-6, where the addition of H 2 O 2 to [Fe II /EDTA] 2-(reaction 1, k 1 = 7-17.5 × 10 3 M -1 s -1 ), 26 is followed by the elimination of a molecule of HO -or H 2 O (reactions 2 and 3). 18, [31] [32] [33] Any of these iron-oxo complexes generated through reactions 2 and 6 are able to react through either electron transfer or hydrogen-atom abstraction with substrates, here PTH (1-34) . 18, 33, 37, 38 Experiments under Air-The presence of O 2 can change the nature of the intermediates leading to the primary oxidizing species. The oxidation of aqueous Fe II , Fe II aq , can be written as an O 2 -and HO --dependent reaction (reaction 7) with an oxidation rate described by eq E1 in the pH range 4-8 (in bicarbonate solutions). 39
If the oxidation of Fe II aq is only described by reaction 7 (and eq E1), the primary oxidizing species is HO 2 • /O 2 •-, or the dismutation product, H 2 O 2 (reaction 8). (8) However, reaction 7 has to be re-evaluated when ferrous iron is chelated. Indeed, the reaction order on Fe II aq may vary from first to second order. This reaction order dependency can be related to the pH and concentration of the Fe II chelate. In the presence of chelators such as EDTA, DTPA, and nitrilotriacetate (NTA) there is general agreement that above pH 6 the reaction with O 2 is pH-independent. 40 The increase of the order of reaction in ferrous chelate with increasing concentrations of ferrous chelate is explained by reactions 9-13 (where L represents a chelator). 40 A short discussion about the order of the reaction on ferrous iron and oxygen is warranted if we want to evaluate the degree of oxidation of iron in the [Fe II (EDTA)] 2-/O 2 complex under our experimental conditions.
(10)
At the lowest concentration of ferrous chelate (≤100 μM), reaction 8 is likely to be ratecontrolling, while reaction 11 is negligible. An increase of the concentration of ferrous chelate should promote reaction 11 such that, at some point, it will compete against reaction 10, resulting in a change of the order of the reaction from one to two. Importantly, under our conditions of oxidation of PTH(1-34), with [Fe II (EDTA)] 2-= 100 μM, the major oxidizing species is likely a peroxo-iron complex, as referred to in equilibrium 14, and illustrated in Scheme 1.
Hydrolysis of the Peptide Bond between Met[8] and His[9]
The hydrolysis of the peptide bond between Met [8] and His [9] requires Fe II , O 2 , and a pH at which the imidizole nitrogen is deprotonated (P2 was not formed at pH 4.5 in Exp 5), consistent with the necessity of the imidazole side chain for coordination of Fe II . The hydrolysis proceeds in the presence of EDTA but not DTPA and proceeds in the presence of acetate but not phosphate. Our results show that the formation of P2 is inhibited through the oxidation of Met [8] and that H 2 O 2 is not required for hydrolysis ( Figures 6B vs D and 8) .
The replacement of Met [8] by Ala [8] in the PTH(1-34)Met [8] Ala mutant as well as the preoxidation of Met [8] into MetSO prevent the hydrolysis of the peptide bond between Met[8] (or Ala [8] ) and His [9] in PTH(1-34) (and the PTH(1-34) Met [8] /Ala mutant). These results suggest that the hydrolysis between Met [8] and His [9] requires an unmodified Met sulfur. We believe that the role of this intact sulfur is not coordination of Fe II but the formation of sulfide radical cations as precursors for hydrolysis.
The formation of P2 is also prevented by (i) chelation of is formed when PTH(1-34) is exposed to air prior to the addition of DTPA ( Figure 7A ).
Based on all the experimental observations, we propose the mechanism detailed in Scheme 1. Complexation of [Fe II (EDTA)] 2-to His [9] , followed by oxygen addition to Fe II , leads to a metal-bound peroxyl radical, C1. This peroxyl radical oxidizes the Met [8] sulfur via oneelectron transfer to yield C2 and a ferrous superoxo complex (reaction 14). While the possibility for back electron transfer exists, the intermediary sulfide radical cation will complex with the peptide bond carbonyl function to form a cyclic, three-electron-bonded intermediate C3 (equilibrium 15). Evidence for such cyclic sulfur-oxygen bonded intermediates has been documented for various peptides by time-resolved spectroscopic analysis during pulse radiolysis experiments. 46, 47 In intermediate C3, the complexation of the carbonyl function by the positively charged sulfide radical cation can be compared to the complexation of the peptide bond by other Lewis acids such as H + or transition metals, which leads to hydrolysis of the peptide bond. [48] [49] [50] [51] In fact, kinetic analysis of the stability of sulfur-oxygen three-electron bonded intermediates in peptides have strongly suggested a hydrolysis reaction 52 analogous to that depicted in reaction 16. Subsequently, the remaining sulfur radical cation I 1 can be reduced back by the ferrous superoxo complex (reaction 17), regenerating the initial Fe II (Ln)OO • species.
The hydrolysis process in Scheme 1 is consistent with our experimental observation of O 18 incorporation into product P2 (which results in the shift of its m/z 906.4-908.4, Figure 12) when the oxidation reaction is performed in H 2 O 18 . Importantly, the hydrolysis cannot be inhibited by the addition of CH 3 OH at sufficient concentrations to scavenge hydroxyl radicals. This result is consistent with the mechanism in Scheme 1, which does not involve hydroxyl radicals, and with the fact that O 2 , but not H 2 O 2 (the precursor for hydroxyl radicals) is required for the hydrolysis reaction. The necessity for an unoxidized Met residue for hydrolysis is further indicated by our observation that (i) the replacement of Met [8] by Ala [8] , (ii) the oxidation of Met [8] to MetSO, and (iii) the addition of exogenous Met prevented the hydrolysis reaction.
The hydrolysis mechanism observed under our experimental conditions is different from those reported by Rana and Meares, 53 where reaction between [Fe III (EDTA)] -and H 2 O 2 led to a nucleophile which attacked the peptide bond. Our mechanism clearly requires Met oxidation and is directed via complexation of Fe II to His [9] or Met [8] . From a pharmaceutical viewpoint, the fact that the addition of EDTA cannot prevent the hydrolysis is important, as EDTA is frequently used as a chelator to prevent metal-catalyzed reactions in formulations. 54 We did not observe the hydrolysis of the peptide bond between Met [8] and His [9] in the presence of phosphate buffer. We did not investigate in detail the reason why the hydrolysis did not occur in the presence of phosphate. Mechanistic evidence suggests a complex formation between phosphate and sulfide radical cations, which may interfere with equilibrium 15 and, consequently, with the hydrolysis reaction. 55 We know that phosphate can have a significant influence on the chemistry of sulfide radical cations. 55 We tentatively rationalize the inhibition of hydrolysis by phosphate with the complexation of the sulfide radical cation by phosphate.
Formation of Homocysteine
The formation of homocysteine proceeds under experimental conditions, which also promote the hydrolysis between Met [8] and His [9] , consistent with our hypothesis of a common intermediate. In fact, the deprotonation of methionine radical cation C2 generates two types of carbon-centered radicals, of which C5 represents a precursor for homocysteine (reaction 18, Scheme 2). 56 In the presence of air, C5 can react with O 2 to form a peroxyl radical, which ultimately leads to the formation of homocysteine (reactions 19-22, Scheme 2).
Oxidation of Met[8] and His[9]
After oxidation of PTH in Ar at pH 6.9 and 7.8, and in accordance with the experimental protocol Exp.5, we observed the oxidation of Met [8] and His [9] into MetSO and 2-oxo-histidine, respectively. Changing the pH to pH 4.5 under otherwise similar conditions, led to complete conversion of Met [8] 16, 31 The quantitation of the oxidation yield of His [9] in wild type PTH was not possible since its oxidation was accompanied by the oxidation of Met [8] . However, in the PTH mutant, the absence of Met [8] allows for the quantitation of oxidation of His [9] . The conversion of His [9] into 2-oxo-histidine in PTH-Met [8] /Ala [8] amounts to ca. 2%.
Oxidation of Met[18], W[23], and His[32]
Our results show that Met [18] , W [23] , and His [32] are not prone to significant oxidation under our experimental conditions. While traces of their oxidation products are observed, their yields are negligible in comparison to the yields of P1 and P2. In contrast, Ji et al. 25 reported significant oxidation on Met [18] and W [23] during metal-catalyzed oxidation of PTH for 24 h (at 40 °C) in air-saturated solutions containing FeCl 2 and H 2 O 2 . We believe that the differential sensitivity of Met [8] and Met [18] toward oxidation may be, in part, caused by secondary structure. The NMR structures 57 of PTH show that Met [8] is located in an α helix whereas Met [18] is not. Our theoretical and experimental studies 58, 59 have shown that a Met residue located within an α-helix can be more sensitive toward oxidation as compared to a Met residue located outside an α-helix. This is due to the facile complex formation between a sulfide radical cation and the peptide bond of the amino acid residue in position i-4.
Significance
Frequently, EDTA is added to pharmaceutical formulations in an attempt to prevent peptide and protein oxidation. . Hence, these data provide evidence that the addition of EDTA may not always protect a peptide or protein from oxidation. Importantly, Met sulfoxide is not the only oxidation product of Met [8] , which also converts to homocysteine. Moreover, both in the absence and presence of EDTA, Fe II catalyzes the site-specific cleavage of the peptide bond between Met [8] and His [9] , a mechanism likely depending on the intermediary formation of a one-electron oxidized Met residue. We note that the Fe II /Fe III concentrations used in our experiments are significantly higher than those one would expect in pharmaceutical formulations. Hence, the yield of hydrolysis/oxidation products under formulation conditions can be expected to be lower. Our results further substantiate that Fe III , the iron species pharmaceutical preparation most frequently encountered, will generate predominantly methionine sulfoxide, not hydrolysis. However, Fe II may be generated through the reaction of Fe III with contaminating peroxides, providing a potential route to hydrolysis. The question is whether the addition of EDTA can actually promote such hydrolytic processes in larger proteins such as antibodies, for example through keeping Fe II (or Fe III ) in solution.
CONCLUSION
Under relatively mild metal-catalyzed oxidation conditions, the oxidation of PTH(1-34) is site-specific. Only Met [8] and His [9] are readily oxidized under conditions where all six amino acid residues, Met [8] , His [9] , Met [18] , Trp [23] , His [32] , and Phe [34] could have been oxidized. A one-electron oxidized intermediate, a radical cation of Met [8] leads to a selective hydrolytic cleavage between Met [8] and His [9] . We hypothesize that the particular spatial conformation of Met [8] and His [9] renders this region sensitive to metal-catalyzed oxidation and hydrolysis. The radical cation of Met [8] is likely at the origin of the Schematic representation of the processes used to oxidize and digest PTH . Pathways a and b describe processes performed under air and Ar, respectively. Percentage of conversion of the tryptic fragment F5 into products P1 and P2 after oxidation of PTH(1-34) under the experimental conditions Exp. 1-6 as described in Section 2.2 and schematized in Figure 2 . The bars indicate the lowest and highest ratios of transformation of F5 into P1 and P2 over five replicates. CID mass spectrum obtained by means of a SYNAPT mass spectrometer of product P1 (m/z 736.4, doubly charged) generated after oxidation of PTH(1-34). CID mass spectrum obtained by means of a SYNAPT mass spectrometer of product P2 (m/z 906.4) generated after oxidation of PTH(1-34). LC-MS analysis of oxidized PTH(1-34) (24.3 μM) under Ar in the presence of DTPA (100 μM) and H 2 O 2 (100 μM). Catalase (0.07 μM) was added under Ar. CID mass spectrum obtained by means of a FT-ICR mass spectrometer of product P4 (m/z 721.4, doubly charged) generated after oxidation of PTH . X stands for the homocysteine residue. CID mass spectrum obtained by means of a FT-ICR mass spectrometer of product P4-NEM (m/z 721.4, doubly charged) generated after oxidation of PTH . "u 1 " and "u 2 " stand for the homocysteine and C-terminal lysine residues derivatized with NEM, respectively.
Scheme 2.
Postulated Reaction Mechanism to Rationalize the Transformation of Met [8] into Homocysteine during Oxidation of PTH Figure S1 F2 KLQDVHNF Figure S2 F3 LQDVHNF Figure S3 F4 VEWLR Figure S4 F5 SVSEIQLMHNLGK Figure S5 F5A SVSEIQLAHNLGK Figure S10 P1 SVSEIQLM ox HNLGK Figure 4 P2 SVSEIQLM Figure 5 P3 SVSEIQLM ox H ox NLGK Figure S6 P4 SVSEIQL(Hcys)HNLGK Figure 13 P2A SVSEIQLA not observed a M ox and H ox stand for methionine sulfoxide and 2-oxo-histidine, respectively. In product P4, Hcys represents homocysteine. Exp. 2 formation of P1 only. See Figure 6C Exp. 3 formation of P1 and P2. See Figure 6 Exp. 4 formation of P1 with much lower yield than those observed in previous protocols. Increase of the yield of P2. See Figure 6E Exp. 5 formation of P1 and P2. See Figure 7A Exp. 6 formation of P1 only. See Figure 7B Exp. 7 complete oxidation of Met [8] into MetSO (P1). P2 is not formed. See Figure 8A Exp. Exp. 1 with PTH mutant (Met [8] was replaced by Ala [8] )
absence of the hydrolytic cleavage between Ala [8] and His [9] . See Figure 11D Exp. 1 and excess of exogenous Met formation of P2 is prevented
Preoxidation of Met residues to MetSO and His to 2-oxo-histidine prior to apply the experimental protocol Exp. 1 formation of P2 is prevented
